Gilead Sciences Supports HarborPath's HIV/AIDS Medication Assistance Pilot Program

  Gilead Sciences Supports HarborPath's HIV/AIDS Medication Assistance Pilot
                                   Program

− HarborPath Partners Now Include Gilead Sciences, Merck and ViiV Healthcare -

PR Newswire

COLUMBIA, S.C., April 24, 2013

COLUMBIA, S.C., April 24, 2013 /PRNewswire/ --HarborPath, an organization
which provides a single point of access to HIV/AIDS medications through
patient assistance programs, welcomes Gilead Sciences as a participating
company. Gilead joins Merck and ViiV Healthcare as the third pharmaceutical
company to support HarborPath since its launch in July 2012.

"With Gilead's support of this pilot program, we can extend the reach of the
organization and offer access to a broader-range of HIV/AIDS medications,"
said Ken Trogdon, Jr., President of HarborPath. "We are thankful for the
support of our pharmaceutical company partners and we urge others to join our
efforts to serve individuals who need access to medications through patient
assistance programs. These programs are a safety net for those who cannot
afford their medications and they provide access to the life-saving drugs that
allow people living with HIV/AIDS to live longer and healthier lives."

HarborPath is currently piloting the program in six states and Washington,
D.C., having most recently added a clinic in South Carolina. HarborPath
provides a streamlined process for healthcare professionals and case managers
to connect individuals living with HIV/AIDS to multiple patient assistance
programs using the common application form on the HarborPath website. The
donated medications are delivered at no cost to qualified individuals through
HarborPath's contracted mail-order pharmacy.

"Access to medicines should never be a barrier to care, and I'm encouraged by
HarborPath's efforts to ensure streamlined access to life-saving medications
for people living with HIV/AIDS," said Congresswoman Barbara Lee of
California, Co-Chair of the Congressional HIV/AIDS Caucus. "All stakeholders,
including the government, private sector, faith communities, and the
philanthropic community have an important role to play to ensure HIV/AIDS
medications reach those who need them."

About HarborPath

HarborPath is a 501(c) (3) organization whose mission is to provide
streamlined access to HIV/AIDS medications through patient assistance programs
via an online portal. For more information, visit www.harborpath.org.

SOURCE HarborPath

Website: https://www.harborpath.org
Contact: Mike Beyer, Sam Brown Inc. PR for HarborPath, 312-961-2502,
beyer@sambrown.com; Ken Trogdon, Jr., President, HarborPath, 803-807-9159,
ken.trogdon@harborpath.org